Associated Banc Corp Sells 3,075 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Associated Banc Corp reduced its stake in Roche Holding AG (OTCMKTS:RHHBY) by 6.9% during the 4th quarter, Holdings Channel reports. The firm owned 41,265 shares of the company’s stock after selling 3,075 shares during the period. Associated Banc Corp’s holdings in Roche were worth $1,454,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in RHHBY. Bard Financial Services Inc. raised its stake in Roche by 37.7% during the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock worth $3,866,000 after buying an additional 30,350 shares during the period. Altrius Capital Management Inc raised its stake in Roche by 0.3% during the 4th quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock worth $6,399,000 after buying an additional 603 shares during the period. Diversified Trust Co raised its stake in Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock worth $2,130,000 after buying an additional 711 shares during the period. Hantz Financial Services Inc. raised its stake in Roche by 0.9% during the 4th quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock worth $1,176,000 after buying an additional 305 shares during the period. Finally, Brooklyn Investment Group raised its stake in Roche by 36.6% during the 4th quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after buying an additional 363 shares during the period.

Wall Street Analyst Weigh In

Several analysts recently commented on RHHBY shares. UBS Group raised Roche from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 13th. Sanford C. Bernstein raised Roche to a “strong-buy” rating in a research note on Thursday, January 30th. Finally, Morgan Stanley started coverage on Roche in a research note on Wednesday, February 12th. They issued an “equal weight” rating on the stock. Two analysts have rated the stock with a sell rating, one has given a hold rating, one has given a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, Roche has an average rating of “Moderate Buy”.

Roche Stock Performance

RHHBY opened at $43.25 on Friday. The business’s 50-day moving average price is $39.81 and its two-hundred day moving average price is $38.53. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $43.96. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.